“In vivo anticancer activities of Ni (II)-Benzoin thiosemicarbazone complex [Ni(BTSC)2] against ehrlich ascites carcinoma cells” (2018) Journal of Bio-Science, 23, pp. 77–88. doi:10.3329/jbs.v23i0.37470.